HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.

Abstract
Leukocyte adherence inhibition (LAI) assay was used to evaluate cell-mediated immunity in patients with invasive squamous cell carcinoma of the cervix. The reactivity of the peripheral blood leukocytes of these patients was evaluated after incubation with pooled extracts of allogeneic squamous cell carcinoma of the cervix. One hundred sixty-seven sets of LAI assays were performed on 54 individuals, including 23 patients with Stage I squamous cell carcinoma of the cervix, 9 patients with other stages of this tumor, 9 patients with unrelated tumors and 13 normal healthy volunteers. A protein concentration of one milligram per milliliter in the tumor extract and 10% fetal bovine serum in the feeding media gave the best results. Eighty-seven percent (28/32) of patients with squamous cell carcinoma of the cervix showed marked specific reactivity. No difference was found in the LAI indices of different stages of the disease.
AuthorsM M Dini, L Lenzi, I Faiferman
JournalAmerican journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction (Am J Reprod Immunol (1980)) Vol. 3 Issue 4 Pg. 188-90 (Jun 1983) ISSN: 0271-7352 [Print] United States
PMID6881415 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Potassium Chloride
Topics
  • Adult
  • Aged
  • Antigens, Neoplasm (immunology, isolation & purification)
  • Carcinoma, Squamous Cell (immunology)
  • Female
  • Humans
  • Immunity, Cellular
  • Leukocyte Adherence Inhibition Test
  • Middle Aged
  • Neoplasms (immunology)
  • Potassium Chloride
  • Uterine Cervical Neoplasms (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: